Utility of combining MMP-9 enzyme-linked immunosorbent assay and MMP-9 activity assay data to monitor plasma enzyme specific activity

Analytical Biochemistry

Volumn 404, Issue 2, 2010, Pages 232-234

  Grierson, C ^a   Miller, D ^b   LaPan, P ^c   Brady, J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Pfizer Global Research and Development   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; CHEMICAL MODIFICATION; ENERGY TRANSFER; ENZYME ACTIVITY; FORSTER RESONANCE ENERGY TRANSFER;

ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; INHIBITORY EFFECT; MATRIX METALLOPROTEINASE 9 (MMP 9); METALLOPROTEINASES; SPECIFIC ACTIVITY; TERMINAL PORTIONS; TISSUE INHIBITOR;

ENZYME INHIBITION;

4 AMINOPHENYLMERCURIC ACETATE; ENZYME PRECURSOR; GELATINASE B; HEPARIN; LITHIUM; TISSUE INHIBITOR OF METALLOPROTEINASE 1; 4-AMINOPHENYLMERCURIACETATE; PHENYLMERCURIC ACETATE;

ARTICLE; BINDING SITE; CHEMICAL MODIFICATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; PLASMA; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; BLOOD; CHEMISTRY; PROCEDURES;

BINDING SITES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; MATRIX METALLOPROTEINASE 9; PHENYLMERCURIC ACETATE; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 77954455311     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.05.020     Document Type: Article

References (13)

1. Wilhelm S.M., Collier I.E., Marmer B.L., Eisen A.Z., Grant G.A., Goldberg G.I. SV40-transformed human lung fibroblasts secrete a 92kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 1989, 264:17213-17221.
2. Birkedal-Hansen H., Moore W.G.I., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., Engler J.A. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 1993, 4:197-250.
3. Morodomi T., Ogata Y., Sasaguri Y., Morimatsu M., Nagase H. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem. J. 1992, 285:603-611.
4. Smith V.A., Rishmawi H., Hussein H., Easty D.L. Tear film MMP accumulation and corneal disease. Br. J. Ophthalmol. 2001, 85:147-153.
5. Carstanjen D., Ulbricht N., Iacone A., Regenfus M., Salama A. Matrix metalloproteinase-9 (gelatinase B) is elevated during mobilization of peripheral blood progenitor cells by G-CSF. Transfusion 2002, 42:588-596.
6. Robertson L., Grip L., Mattson Hultén L., Hulthe J., Wiklund O. Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention. J. Intern. Med. 2007, 262:659-667.
7. Oshita Y., Koga T., Kamimura T., Matsuo K., Rikimaru T., Aizawa H. Increased circulating 92kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma. Thorax 2003, 58:757-760.
8. Morgia G., Falsaperla M., Malaponte G., Madonia M., Indelicato M., Travali S., Mazzarino M.C. Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer. Urol. Res. 2005, 33:44-50.
9. Somiari S.B., Shriver C.D., Heckman C., Olsen C., Hu H., Jordan R., Arciero C., Russell S., Garguilo G., Hook J., Somiari R.I. Cancer Lett. 2006, 233:98-107.
10. Bauvois B., Mothu N., Nguyen J., Nguyen-Khoa T., Noel L.H., Jungers P. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1, and TGF-β1 in patients with distinct types of primary glomerulonephritis. Nephrol. Dial. Transplant 2007, 22:1115-1122.
11. Chang Y.-H., Lin I.-L., Tsay G.J., Yang S.-C., Yang T.-P., Ho K.-T., Hsu T.-C., Shiau M.-Y. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin. Biochem. 2008, 12:955-959.
12. Vernooy J.H.J., Lindeman J.H.N., Jacobs J.A., Hanemaaijer R., Wouters E.F.M. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest 2004, 126:1802-1810.
13. Ahrens D., Koch A.E., Pope R.M., Stein-Picarella M., Niedbala M.J. Expression of matrix metalloproteinase 9 (96-kDa gelatinase B) in human rheumatoid arthritis. Arthritis Rheum. 1996, 39:1576-1587.